NCI announces funding opportunities for exploratory/development research and also for small research projects
PAR-12-145: NCI Exploratory/Developmental Research Grant Program
The purpose of this funding opportunity announcement is to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance cancer research in all areas relevant to the mission of the NCI. By using the R21 mechanism, this FOA will support "Exploratory/Developmental projects." These studies may involve considerable risk but may lead to a breakthrough in a particular area, and/or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical). Applications submitted under this mechanism should have a clear potential to break new ground and/or extend previous discoveries toward new directions or applications.
The combined budget for direct costs for the 2-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year. Applicants may request direct costs in $25,000 modules, up to the total direct costs limitation of $275,000 for the combined 2-year award period. The maximum project period is 2 years.
PAR-12-144: NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
This funding opportunity announcement supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
A budget for direct costs of up to $50,000 per year may be requested with a maximum of $100,000 direct costs over 2 years). The scope of the proposed project should determine the project period. The maximum period is 2 years.